N
PGNX

Natixis’s Progenics Pharmaceuticals Inc PGNX Stock Holding History

Natixis’s Portfolio PGNX Stock Details PGNX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-17,463
Closed -$112K – 1009
2017
Q4 		$112K Buy
17,463
+2,463
+16% +$15.8K ﹤0.01% 805
2017
Q3 		$110K Buy
+15,000
New +$110K ﹤0.01% 1180